The use of nebulized opioids for breathlessness: a chart review

Abstract

Breathlessness secondary to both cancer and non-malignant disease is a distressing, exhausting symptom which, to date, has been difficult to control. This paper reports a chart review undertaken on patients referred to the Ottawa Civic Hospital's Palliative Care Service over the 18-month period from 1 January 1992 to 30 June 1993. The intent of the review was to assess the recorded efficacy and safety of nebulized opioid use on patients with complaints of dyspnoea. Fifty-four patients were treated and subjective data have been compiled. The treatment was found to be effective, safe and convenient for the majority of the patients studied. In addition, nebulized opioids have been demonstrated as a treatment modality which is feasible for self-administration by the patient at home.

Keywords

dihydromorphinone dyspnoea morphine nebulizers and vaporizers palliative treatment

Get full access to this article

View all access options for this article.

References

Cowcher K. , Hanks G. Long-term management of respiratory symptoms in advanced cancer. J Pain Symptom Manage 1990; 5: 320-30.

Reuben D. , Mor V. Dyspnoea in terminally ill cancer patients. Chest 1986; 89: 234-36.

Bruera E. , de Stoutz N. , Velasco-Leiva A. , Schoeller T. , Hanson J. Effects of oxygen on dyspnoea in hypoxaemic terminal cancer patient. Lancet 1993; 342: 13-14.

de Conno F. , Spoldi E. , Caraceni A. , Ventafridda V. Does pharmacological treatment affect the sensation of breathlessness in terminal cancer patients? Palliat Med 1991; 5: 237-43.

Chater S. (1991) Management of terminal dyspnoea. Pain Management Newsletter- Top Pain Manage Symptom Control, 1991; 4(2): 3-5.

Ahmedzai S. , Carter R. , Mills RJ , Moran F. Effects of nabilone on pulmonary function. In: Harvey DJ, Nahas GG, Paton WDM eds. Proceedings of the 9th International Congress of Pharmacology: Marijuana 1984, 3rd Satellite Symposium on Cannabis. Oxford: IRL Press, 1985: 371-78.

Light R. , Muro J. , Sato R. , Stansbury DW , Fischer CE , Brown SE Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 139: 126-33.

Bruera E. , Macmillan K. , Pither J. , MacDonald N. Effects of morphine on the dyspnoea of terminal cancer patients. J Pain Symptom Manage 1990; 5: 341-44.

Young H. , Daviskas E. , Keena VA Effects of low dose nebulized morphine on exercise endurance in patients with chronic lung disease. Thorax 1989; 4: 387-90.

10.

Regnard C. , Ahmedzai S. Dyspnoea in advanced cancer - a flow diagram. Palliat Med 1990; 4: 311-15.

11.

Farncombe M. , Chater S. Case studies outlining use of nebulized morphine in patients with end-stage chronic lung and cardiac disease. J Pain Symptom Manage 1993 ; 8: 221-25.

12.

Farncombe M. , Chater S.

Clinical application of nebulized opioids for treatment of dyspnea in patients with malignant disease. Supportive

Care Cancer 1994; 2: 184-87.

13.

Farncombe M. Nebulized opioids in the management of breathlessness . Pain Manage Newsletter- Top Pain Manage Symptom Control 1993; 6(2): 1-3.

14.

Hughes S. , Calverley Pma. Heroin inhalation and asthma. Br Med J 1988 ; 297: 1511-12.